Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program

In August 2006, the Australian government approved subsidized trastuzumab therapy for human epidermal growth factor receptor 2 (HER2)-positive early breast cancer, and it was mandated that HER2 testing should be performed using in situ hybridization (ISH) rather than immunohistochemistry (IHC). Here...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Bilous, Michael, Morey, Adrienne L., Armes, Jane E., Bell, Richard, Button, Peter H., Cummings, Margaret C., Fox, Stephen B., Francis, Glenn D., Waite, Brigid, McCue, Glenda, Raymond, Wendy A., Robbins, Peter D., Farshid, Gelareh
Format: Artigo
Sprog:Inglês
Udgivet: Springer US 2012
Fag:
Preclinical Study
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3401497/
https://ncbi.nlm.nih.gov/pubmed/22678156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-012-2093-6
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker